A second Australian tennis player in four months has been provisionally suspended for breaching the sport’s anti-doping rules over intravenous infusion of vitamins. Thomas Fancutt, 30, confirmed his suspension on social media on Tuesday after it was announced by the sport’s anti-doping watchdog, the International Tennis Integrity Agency (ITIA) on the weekend. His case followed that of dual doubles grand slam champion Max Purcell whose ban started in December and meant he missed January’s Australian Open. Both players have admitted to using a “prohibited method” as defined by the ITIA’s anti-doping program. Athletes are permitted to use IV drips, but only when fluid is below a certain threshold and within a specific time period. In the case of Fancutt, the world No.123 doubles player who made his grand slam debut at Melbourne Park two months ago, he said he received a 500ml IV infusion late last year “to combat severe fatigue” and he was “devastated” by his ban. His provisional suspension started on 19 March.